ONCIMMUNE LEADING EARLY CANCER DETECTION
 
ONCIMMUNE LEADING EARLY CANCER DETECTION
Date Title Link/PDF
12 -15 November Oncimmune are exhibiting at... Medica, Messe Dusseldorf, Germany. Hall 3a, Stand C07-2 Oncimmune are exhibiting at...
13 - 16 October Dr James Jett, Chief Medical Officer, Oncimmune US, is speaking at... Turkish Respiratory Society National Congress, Antalya Turkey Dr James Jett, Chief Medical Officer, Oncimmune US, is speaking at...
11 October Mike Fisher, Commercial Director Oncimmune will be speaking at... Private Acute Healthcare Conference, The Royal Society of Medicine, London Mike Fisher, Commercial Director Oncimmune will be speaking at...
4 - 7 October Dr James Jett, Chief Medical Officer, Oncimmune US, is speaking at... National Lung Cancer Congress, Bodrum, Turkey Dr James Jett, Chief Medical Officer, Oncimmune US, is speaking at...
25 September at 16:45 Dr James Jett, Chief Medical Officer, Oncimmune US, is presenting at... 19th World Conference on Lung Cancer Toronto, Canada. Oncimmune will be at Booth 2904 Dr James Jett, Chief Medical Officer, Oncimmune US, is presenting at...

PLEASE READ THE FOLLOWING STATEMENT CAREFULLY

Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept